GlassScriptPhysician profile
Zandra H Cheng
NPI 1841299708
$446.75
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $432 · 2020: $15.24.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $148.85 | 2019 | |
| Puma Biotechnology, INC. | $33.75 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $30.28 | 2019 | |
| Incyte Corporation | $29.98 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $29.87 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $24.21 | 2019 | |
| Eisai INC. | $22.73 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $22.45 | 2019 | |
| Alexion Pharmaceuticals, INC. | $20.23 | 2019 | |
| Amag Pharmaceuticals, INC. | $17.79 | 2019 | |
| Rigel Pharmaceuticals, INC. | $15.60 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $15.46 | 2019 | |
| Janssen Biotech, INC. | $13.36 | 2019 | |
| Jazz Pharmaceuticals INC. | $11.20 | 2019 | |
| Amgen INC. | $10.99 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zandra Cheng listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.